Russian Military Medical Academy ReportsRussian Military Medical Academy Reports2713-23152713-2323Eco-Vector8119710.17816/rmmar81197Review ArticleHLA typing methods used for organ and tissue transplantationKolyubaevaSvetlana N.<p>D.Sc. (Biology)</p>ksnwma@mail.ruhttps://orcid.org/0000-0003-2441-9394MyakoshinaLiliya A.lmyakoshina@yandex.ruhttps://orcid.org/0000-0002-2498-6201EliseevaMarina I.eliceewa@yandex.ruhttps://orcid.org/0000-0001-7731-7661GlushakovRuslan I.<p>M.D., D.Sc. (Medicine)</p>Glushakovruslan@gmail.comhttps://orcid.org/0000-0002-0161-5977S.M. Kirov Military Medical Academy1407202140221322709202112122021Copyright © 2021, Kolyubaeva S.N., Myakoshina L.A., Eliseeva M.I., Glushakov R.I.2021<p>The antigen system on the surface of human cells is responsible for recognizing foreign antigens. In organ transplantation, the immune system reacts to all foreign antigens that are different from the recipients antigens. In practice, solid organ transplantation is carried out with varying degrees of genetic discrepancy, while the main principle that should be followed to prevent acute and chronic transplant rejection reactions is to avoid unacceptable discrepancies. As a result, the diagnosis of typing genes of histocompatibility allows you to select a donor to which the recipient will not have sensitization. The article presents an analysis of various methods for typing human histocompatibility genes for organ and tissue transplantation. The discovery of the polymerase chain reaction was a new stage in the typing of human histocompatibility genes, which made it possible to develop new methods of gene typing. As a result, methods have been developed for typing genes using sequencers, including a new-generation MiSeq sequencer (<em>Illumina</em>, USА), a Massarray genomic time-of-flight analyzer (<em>Agena Bioscience</em>, USA). The use of sequencing has led to the possibility of simultaneous typing from 24 to 100 DNA samples. Modern technological solutions have made it possible to improve the 3rd generation NGS sequencers and provide a maximum productivity of up to 30 billion nucleotides per run, minimize restrictions on the length of DNA readings, as well as track parameters, control the sequencing process and conduct base-scaling in real time. Modern data using rapid genes typing of the human histocompatibility system (MinION Oxford nanopore) meet the needs of particularly sensitive recipients. Preliminary evidence suggests that this method will be more economical and efficient and will replace all previous ones over time (8 figs, bibliography: 40 refs).</p>allelesdonorsgenesHLA typingpolymerase chain reactionrecipientssequencingаллелигеныдонорыHLA-типированиеполимеразная цепная реакцияреципиентысеквенирование[World Health Organization. WHO guidelines on transplantation of human cells, tissues, and organs. Available at: https://www.who.int/transplantation/Guiding_PrinciplesTransplantation_WHA63.22ru.pdf (accessed 07.05.2021). (In Russ.)][Guidelines for diagnostic laboratory management of solid organ transplantation: a practical guide. Translation from English. Moscow: Biokhimmak Publisher; 2013. 16 p. (In Russ.)][Gordeeva LA, Shabaldin AV, Glushkov AN. Influence of non-inherited parental HLA on the immune response in offspring. Meditsinskaya immunologiya. 2006;8(5–6):587–596. (In Russ.)][Yankevich T. Development of a typing system for HLA classes I and II genes at a high resolution using high-throughput sequencing (NGS). Ph.D. (Medicine) thesis. Moscow: Institute of Immunology FMBA of Russia Publishing House; 2018. (In Russ.)][Bondareva MN. HLA (class II) and natural selection. “Functional” genotype, hypothesis of the advantage of “functional” heterozygosity. D.Sc. (Medicine) thesis. Moscow: Institute of Immunology, FMBA of Russia Publishing House; 2007. (In Russ.)][Budchanov YuI. Cellular immunity. Types of cellular cytotoxicity. Receptors and markers, lymphocyte subpopulations: a teaching aid in general immunology. Tver; 2008. 11 p. (In Russ.)][Kolyubaeva SN, Gorichny VA, Protasov OV, et al. HLA-typing methods used for organ and tissue transplantation. Bulletin of the Military Innovative Technopolis “ERA”. 2021;2(1):21–30. (In Russ.)][Savchenko VG, ed. Temporary guidelines regulating HLA typing of bone marrow/hematopoietic stem cells donors and interaction of bone marrow donor registries. Moscow: Federal State Budgetary Institution “National Medical Research Center of Hematology” Ministry of Health of the Russian Federation Publishing House; 2021. 34 p. (In Russ.)][Formation and maintenance of a waiting list for transplantation of a cadaveric organ. Algorithm for selecting the optimal donor–recipient pair. National clinical guidelines. Moscow: Russian Transplant Society Publishing House; 2015. 33 p. (In Russ.)][European Federation for Immunogenetics. Standards for histocompatibility & immunogenetics testing (Version 8.0). 2020. 40 p. Available at: https://efi-web.org/fileadmin/Efi_web/Standardv8_280819.pdf (accessed 05.05.2021).][EFI-web. Standards for Histocompatibility & Immunogenetics testing. Available at: https://efi-web.org/committees/standards-committee (accessed 05.05.2021).][Zaretskaya YuM. Clinical immunogenetics. M.: Meditsina Publisher; 1983. 208 p. (In Russ.)][Touter EA. General principles for studying the specific activity of monoclonal antibodies in preclinical studies as a basic indicator of their biological similarity. Ph.D. (Biology) thesis. Volgograd; 2017. (In Russ.)][Mittal KK, Mickey MR, Singal DP, Terasaki PI. Refinement of microdroplet lymphocyte cytotoxicity test. Transplantation. 1968;6(8):913–927.][Basics of polymerase chain reaction (PCR). Methodological manual. Moscow: DNA Technology Publisher; 2012. 151 р. (In Russ.)][Higuchi R, Von Beroldingen CH, Sensabaugh GF, Erlich HA. DNA typing from single hairs. Nature. 1988;332(6164):543–546.][Milbury CA, Li J, Liu P, Makrigiorgos GM. COLD-PCR: improving the sensitivity of molecular diagnostics assays. Expert. Rev. 2011;11:159–169.][Granados DP, Sriranganadane D, Daouda T, et al. Impact of genomic polymorphisms on the repertoire of human MHC class I-associated peptides. Nature Communications. 2014;5(1): 1–14.][Clag US, Cummings MR, Spencer ShA, et al. Fundamentals of genetics. Lushnikova A.A., Musatkina S.M., translation from English. Moscow: Tekhnosfera Publisher; 2016. 944 p.][Loginova MA, Trofimova NP, Paramonov IV, Trofimova NP, Paramonov IV. Analysis of the frequency of detecting ambiguities of loci during HLA typing using the SSO technology. Clinical laboratory diagnostics. 2012;4:29–32. (In Russ.)][Madden K, Chabot-Richards D. HLA testing in the molecular diagnostic laboratory. Virchows Arch. 2019;474(2):139–147. DOI: 10.1007/s00428-018-2501-3][Cargou M, Ralazamahaleo M, Blouin L, et al. Improvement in HLA-C typing by a new sequence-specific oligonucleotides kit. HLA. 2020;96(3):323–328. DOI: 10.1111/tan.13986][PROTRANS version RU03 S4-S1: user manual. Protrans medizinische diagnostische Produkte; 2015. 36 p.][Kaur N, Pinelli D, Kransdorf EP, et al. A blueprint for electronic utilization of ambiguous molecular HLA typing data in organ allocation systems and virtual crossmatch. Hum Immunol. 2020;81(1–3): 65–72. DOI: 10.1016/j.humimm.2020.01.007][Barkhatov IM, Predeus AV, Chukhlovin AB. Sequencing of a new generation and its application in oncohematology. Oncohematology. 2016;11(4):56–63. (In Russ.)][Illumina. Nextera XT Library Prep: Tips and Troubleshooting. Available at: https://www.illumina.com/content/dam/illumina-marketing/documents/products/technotes/nextera-xt-troubleshooting-technical-note.pdf (accessed 01.05.2021).][Rebrikov DV, ed. NGS high throughput sequencing. Moscow: Binom Publisher; 2014. 231 р. (In Russ.)][Gross AM, Guerrieri RA. HLA DQA1 and Polymarker validations for forensic casework: standard specimens, reproducibility, and mixed specimens. J Forensic Sci. 1996;41(6):1022–1026. DOI: 10.1520/JFS14041J][Kubo S, Fujita Y, Yoshida Y, et al. Personal identification from skeletal remain by D1S80, HLA DQA1, TH01 and polymarker analysis. J Med Invest. 2002;49(1–2):83–86.][Harrington CS, Dunaiski V, Williams KE, Fowler C. HLA DQα typing of forensic specimens by amplification restriction fragment polymorphism (ARFP) analysis. J. Forensic Sci. 1991;51(1):147–157.][Wang Y, Xiao J, Yang S, Zhang X. Second harmonic generation spectroscopy on two-dimensional materials. Optical Materials Express. 2019;9(3):1136–1149. DOI: 10.1364/OME.9.001136][Chemeris DA, Sagitov AM, Aminev FG, et al. Evolution of approaches to DNA identification of a person. Biomics. 2018;10(1): 85–140. (In Russ.)][Bowes J, Thyberg J, Dahlstom O, et al. Comprehensive assessment of rheumatoid arthritis susceptibility loci in a large psoriatic arthritis cohort. Annals of the Rheumatic Diseases. 2012;71(8): 1350–1354. DOI:10.1136/annrheumdis-2011-200802][Nakka P, Raphael BJ, Ramachandran S. Gene and network analysis of common variants reveals novel associations in multiple complex diseases. Genetics. 2016;204:783–798.][Edgerly CH, Weimer ET. The Past, Present, and Future of HLA Typing in Transplantation. Methods Mol Biol. 2018;1802:1–10. DOI: 10.1007/978-1-4939-8546-3_1][Technical Manual. American Association of blood banks: 13th edition. Bethesda, Maryland; 2001:114–125.][Dimo-Simonin N, Brandt- Casadevall C. Evaluation and usefulness of reverse dot blot DNA PolyMarker typing in forensic case work. J Forensic Sci. 1996;81(1):61–72.][Argani H. Anti-HLA Antibody: the role of epitopes in organ transplantation. Exp Clin Transplant. 2019;17:38–42. DOI: 10.6002/ect. MESOT2018. L41][Duke JL, Mosbruger TL, Ferriola D, et al. Resolving MiSeq-generated ambiguities in HLA-DPB1 typing by using the Oxford Nanopore technology. J Mol Diagn. 2019;21(5):852–861. DOI: 10.1016/j.jmoldx.2019.04.009][De Santis D, Truong L, Martinez P, et al. Rapid high resolution HLA genotyping by MinION Oxford nanopore sequencing for deceased donor organ allocation. HLA. 2020;96(2):141–162. DOI: 10.1111/tan.13901]